/People

Hanson S. Gifford, III

Investor

Partner at Lightstone Ventures

United States

Writes $100K – $5M checks · typically $1.5M

Find your path to Hanson

Sign up to see every warm intro you have to Hanson

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Hanson. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Hanson S. Gifford, III is an investor with Lightstone Ventures, a life science venture firm founded in 2012 that backs biotech and medtech founders translating scientific breakthroughs into therapeutics and medical technologies. His investment work spans medical device companies, where he leads deals for Lightstone's LSV fund. He has led the firm's investments in Contego Medical, FIRE1, and Reprieve Cardiovascular, which focus on vascular disease treatment, remote patient monitoring, and acute heart failure fluid management respectively.

Contact· published on Hanson's own website

Invests in

BiotechHealthtechMedical Devices

Deals · 7

Reprieve CardiovascularBoard seat

via Lightstone Ventures · filed Jun 2025 · $35.9M raise

Hat Trick MedicalBoard seat

via Lightstone Ventures · filed Feb 2023 · $1M raise

Contego MedicalBoard seat

via Lightstone Ventures · filed Apr 2022 · $17.5M raise

Allay TherapeuticsBoard seat

via Lightstone Ventures · filed Feb 2019 · $28.8M raise

Tangible ScienceBoard seat

via Lightstone Ventures · filed Nov 2016 · $4.6M raise

Miramar LabsBoard seat

via Lightstone Ventures · filed Jun 2016 · $33.6M raise

TwelveBoard seat

via Lightstone Ventures · filed Apr 2015 · $35.3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Apreo Health

Sources: the investor's own website · SEC Form D filings · curated public sources.

Colleagues at Lightstone Ventures

Network2

Investors connected to Hanson in public investor directories — a warm-intro map.

Frequently asked questions

Who is Hanson S. Gifford, III?
Hanson S. Gifford, III is an investor with Lightstone Ventures, a life science venture firm founded in 2012 that backs biotech and medtech founders translating scientific breakthroughs into therapeutics and medical technologies. His investment work spans medical device companies, where he leads deals for Lightstone's LSV fund. He has led the firm's investments in Contego Medical, FIRE1, and Reprieve Cardiovascular, which focus on vascular disease treatment, remote patient monitoring, and acute heart failure fluid management respectively.
Where does Hanson S. Gifford, III work?
Hanson S. Gifford, III is Partner at Lightstone Ventures.
What does Hanson S. Gifford, III invest in?
Hanson S. Gifford, III invests in Biotech, Healthtech, Medical Devices.
What check size does Hanson S. Gifford, III write?
Hanson S. Gifford, III typically writes checks of $100K – $5M.
What boards does Hanson S. Gifford, III sit on?
Hanson S. Gifford, III holds tracked board seats at Allay Therapeutics, Apreo Health, Contego Medical, Hat Trick Medical, Miramar Labs, Reprieve Cardiovascular, Tangible Science, Twelve.
What companies has Hanson S. Gifford, III invested in?
Investments tracked here include Contego Medical, FIRE1, Reprieve Cardiovascular, Reprieve Cardiovascular.
Does Hanson S. Gifford, III lead rounds?
Yes — Hanson S. Gifford, III has led 3 tracked investments.

Founder mafias

About this profile. Compiled from public sources — Lightstone Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights